Corona Remedies IPO Details

Corona Remedies IPO Sees Strong Momentum on Day 2; Subscription Touches 2x

Created December 9, 2025
Author Bhumish Seth
Reading Time: 2 minutes

Market PerformanceThe sentiment around the Corona Remedies IPO remained firm as the issue entered its second day of bidding on December 9. The pharma company drew steady interest across categories, pushing the overall subscription to around 2 times the offer size.Retail participation also stayed ...

Corona Remedies IPO: Day 1 Subscription, Price Band & Key Details Explained

Created December 8, 2025
Author Bhumish Seth
Reading Time: 2 minutes

The buzz around the Corona Remedies IPO has been building steadily—and Day 1 of the public issue has only amplified the interest. As the pharma company opens its ₹655.37 crore public offer, investors across the retail, QIB, and NII segments are tuning in to understand what the issue looks like, w...

Corona Remedies IPO: Check IPO Date, Lot Size, Price & Details

Created December 6, 2025
Author saurav chaube
Reading Time: 3 minutes

Business Overview:Corona Remedies is an India-focused branded pharmaceutical formulation company operating across key therapeutic segments including women’s healthcare, cardio - diabetics, pain management, urology, and multispecialty care. Incorporated in 2004, the company today has a diversified...

Corona Remedies IPO Details

Corona Remedies IPO Sees Strong Momentum on Day 2; Subscription Touches 2x

Corona Remedies IPO: Day 1 Subscription, Price Band & Key Details Explained

Corona Remedies IPO: Check IPO Date, Lot Size, Price & Details

Filing Complaints on SCORES